Sort
261,768 grants matching “gene therapy”
HCMR Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
$3,367,487Christopher M Kramer · University Of Virginia · U01 · FY2013 · HL
REPRIEVE - CCC - Lead Application
$3,367,267Steven Kyle Grinspoon · Massachusetts General Hospital · U01 · FY2015 · HL
HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation
$3,366,438Christine Marie Durand · Johns Hopkins University · U01 · FY2021 · AI
Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders
$3,366,147Carlos Zarate · National Institute Of Mental Health · ZIA · FY2024 · MH
Genetic Variants, Epigenome and Retinal Disease Phenotypes
$3,365,673Anand Swaroop · National Eye Institute · ZIA · FY2018 · EY
Functional and Mechanistic Characterization of Lupus Susceptibility
$3,364,935Swapan K Nath · Oklahoma Medical Research Foundation · R01 · FY2025 · AI
Salivary Gland Secretion Mechanisms During Normal And Altered Functional States
$3,364,806Bruce J Baum · National Institute Of Dental & Craniofacial Research · Z01 · FY2008 · DE
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$3,363,729Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.
$3,361,716Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2023 · CA
Genetic and Environmental Determinants of Triglycerides
$3,361,710University Of Minnesota Twin Cities · U01 · FY2003 · HL
Pharmacogenetics of Asthma Treatment
$3,361,644Brigham And Women'S Hospital · U01 · FY2005 · HL
Identification of Genes Causing Syndromic and Nonsyndromic Hearing Impairment
$3,359,831Thomas Friedman · National Institute On Deafness And Other Communication Disorders · ZIA · FY2011 · DC
Protein Trafficking In The Endosomal-Lysosomal System
$3,358,310Juan Bonifacino · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD
The next iteration of the AMP-T2D Knowledge Portal
$3,356,424Jason Flannick · Broad Institute, Inc. · UM1 · FY2021 · DK
Retroviral Mediated Gene Transfer Into Primate Hematopoietic Cells
$3,352,669So Gun Hong · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Designer Tregs for restoring tolerance in patients with type 1 diabetes
$3,351,746Jeffrey A Bluestone · University Of California, San Francisco · UC4 · FY2017 · DK
Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE
$3,349,999Mark Thomas Gladwin · University Of Maryland Baltimore · UH3 · FY2023 · HL
Adult Stem Cells for Therapy of Visual Disorders
$3,346,543Martin Friedlander · Scripps Research Institute, The · R24 · FY2008 · EY
Stanford Cancer Institute
$3,345,301Beverly Shriver Mitchell · Stanford University · P30 · FY2016 · CA
The next iteration of the AMP-T2D Knowledge Portal
$3,343,486Jason Flannick · Broad Institute, Inc. · UM1 · FY2022 · DK
Molecular Determinants of Coronary Artery Disease
$3,341,961Edward Franklin Plow · Cleveland Clinic Lerner Com-Cwru · P50 · FY2007 · HL
SPORE in Breast Cancer
$3,341,501University Of North Carolina Chapel Hill · P50 · FY2002 · CA
Periodontitis Role in Inflammatory Bowel Disease
$3,340,009Vivek Thumbigere-Math · University Of Maryland Baltimore · R01 · FY2025 · DK
Stanford Cancer Institute
$3,338,488Beverly Shriver Mitchell · Stanford University · P30 · FY2017 · CA
Small Molecule Ligands Targeting Pathological Tau Signaling In AD And Related Dementias
$3,336,256Scott Thomas Brady · University Of Illinois At Chicago · RF1 · FY2025 · AG